NCT07493512 Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer Status RECRUITING Phase PHASE1
NCT07297979 Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) Status RECRUITING Phase PHASE1
NCT07213674 A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Status RECRUITING Phase PHASE3
NCT07140900 Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer Status RECRUITING Phase PHASE1
NCT06691984 Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06613100 Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer Status RECRUITING Phase PHASE1
NCT06555796 Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1